Ripretinib
Chemical Structure Depiction of
Ripretinib
Ripretinib
Compound characteristics
| Compound ID: | CE06-1693 |
| Compound Name: | Ripretinib |
| Molecular Weight: | 510.36 |
| Molecular Formula: | C24 H21 Br F N5 O2 |
| CAS Number: | 1442472-39-0 |
| Smiles: | CCN1C(C(=Cc2cnc(cc12)NC)c1cc(c(cc1[Br])F)NC(Nc1ccccc1)=O)=O |
| InChI Key: | CEFJVGZHQAGLHS-UHFFFAOYSA-N |
| Short Description: | Ripretinib (DCC-2618) is an orally bioavailable inhibitor of KIT and PDGFRA. |
| Pathway: | Tyrosine Kinase/Adaptors|||Angiogenesis|||Apoptosis |
| Target: | c-Kit|||FLT|||Apoptosis|||VEGFR|||PDGFR |
| Type of molecule: | FDA Approved/Clinical |
| Alias: | DCC-2618 |
| Stock amount: | 1503 |